Dyax

 

Advancing Novel Biotherapeutics Since 1995®

 

Robust and maturing portfolio with diverse therapeutic targets - the proof is in the pipeline®.

Licensee Pipeline

Dyax provides access to its phage display libraries in various types of licenses and collaborations under the Licensing and Funded Research Program (LFRP).

Under the LFRP, we maintain more than 70 licenses and collaborations with various research, biotechnology and pharmaceutical companies. These licenses have advanced into clinical development numerous drug candidates identified using our phage display libraries.

Our licensee pipeline currently consists of 13 clinical-stage drug candidates, including three programs in Phase 3 trials.

*Denotes milestone payment only

 

You are now leaving Dyax.com.

The web site you are about to visit is . It is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?